Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Eur Respir J
.
2017 Feb 23;49(2):1602524.
doi: 10.1183/13993003.02524-2016.
Print 2017 Feb.
Authors
Joseph Jacob
1
,
Andrew G Nicholson
2
,
Athol U Wells
3
,
David M Hansell
4
Affiliations
1
Department of Radiology, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK akelajacob@gmail.com.
2
Department of Pathology, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
3
Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
4
Department of Radiology, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
PMID:
28232420
DOI:
10.1183/13993003.02524-2016
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular System
Disease Progression*
Humans
Idiopathic Pulmonary Fibrosis*
Thorax